Evidence map›Paper›PMID 22269864›Full record

ReviewMolecules (Basel, Switzerland)2011

Phenolic profile of edible honeysuckle berries (genus lonicera) and their biological effects.

Tunde Jurikova, Otakar Rop, Jiri Mlcek, Jiri Sochor, Stefan Balla, Ladislav Szekeres, Alzbeta Hegedusova, Jaromir Hubalek, Vojtech Adam, Rene Kizek

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 145 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Evaluation ofTurkish journal of pharmaceutical sciences · 2022
    Article
  10. Review
  11. The Effective Analysis for Blue Honeysuckle Extract in the Treatment of Hepatocellular Carcinoma.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  12. Antioxidant Effect ofAntioxidants (Basel, Switzerland) · 2021
    Article
  13. Protocols for Adventitious Regeneration ofPlants (Basel, Switzerland) · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. Health Properties and Composition of Honeysuckle BerryMolecules (Basel, Switzerland) · 2020
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Tunde JurikovaFaculty of Central European Studies, Institute of Natural and Informatics Sciences, Constantine the Philosopher University in Nitra, Nabrezie mladeze 91, SK-949 76 Nitra, Slovakia.
Otakar Rop
Jiri Mlcek
Jiri Sochor
Stefan Balla
Ladislav Szekeres
Alzbeta Hegedusova
Jaromir Hubalek
Vojtech Adam
Rene Kizek
Constantine the Philosopher University in Nitra · SKMendel University in Brno · CZTomas Bata University in Zlín · CZBrno University of Technology · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current status of research on polyphenolic compounds in the berries of edible honeysuckle and their biological effects, including recommended utilization, are reviewed. The major classes of phenolic compounds in the blue berried honeysuckle are flavonols (quercetin, rutin, quercitrin) and flavanes (proanthocyanidins, catechins) and anthocyanins. Cyanidin-3-glucoside and cyanidin-3-rutinoside are considered as major anthocyanidins in edible honeysuckle berries. Such a high level of antioxidant activity in the berries of different species of the genus Lonicera is especially due to the high level of polyphenolic compounds, especially anthocyanins. These berries seem to be prospective sources of health-supporting phytochemicals that exhibit beneficial anti-adherence and chemo-protective activities, thus they may provide protection against a number of chronic conditions, e.g., cancer, diabetes mellitus, tumour growth or cardiovascular and neurodegenerative diseases.

Indexed as

AntioxidantsFruitLoniceraMedicine, TraditionalPolyphenolsAntioxidantsPolyphenols

Identifiers

PMID22269864
PMCPMC6268301
OpenAlexW2146099981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.